ROTH Capital Partners is an investment banking firm dedicated to the small-cap public market.
Business Model:
Revenue: $50M
Employees: 51-200
Address: 888 San Clemente Dr
City: Newport Beach
State: CA
Zip: 92660
Country: US
ROTH is an investment banking firm dedicated to the small-cap public market. Since its inception in 1984, ROTH has been an innovator in this market. In the 1990&s;s ROTH participated in underwriting IPOs for small-cap companies. As this market changed, ROTH helped develop the PIPE (private investment in public equity) financing structure. ROTH was one of the first U.S. investment banks to focus on financing small-cap Chinese companies, and established a Representative Office in Shanghai in 2007 and a Hong Kong (Limited) Office in 2010.
Contact Phone:
+18006789147
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2021 | Bally Technologies | Private Equity Round | - |
3/2021 | Array Technologies | Post-IPO Equity | - |
6/2021 | Celsius | Post-IPO Equity | 0 |
3/2021 | Sunworks USA | Private Equity Round | 51.8M |
6/2016 | Smule | Series G | 0 |
4/2020 | Lumitron Technologies | Equity | 34M |
8/2015 | Revel Systems | Series C | 13.5M |
7/2017 | Gazillion, Inc. | Series C | 15M |
7/2015 | RedHill Biopharma | Post-IPO Equity | 40M |
6/2014 | Rant | Venture Round | 0 |
9/2015 | SunBasket | Venture Round | 0 |
7/2000 | Infinilink | Series A | 0 |
4/2016 | Gazillion, Inc. | Series A | 11M |
7/2021 | Riley Permian | Venture Round | 0 |
5/2021 | ADOMANI | Post-IPO Equity | 17.3M |
5/2021 | DMC Global | Funding Round | 129.4M |
10/2014 | LiquidSpace | Series C | 0 |
1/2023 | Akoustis | Post-IPO Equity | 30M |
4/2013 | Celator Pharmaceuticals | Private Equity Round | 39.3M |
8/2013 | SOASTA | Series E | 0 |
4/2014 | Smule | Series E | 16.6M |
6/2021 | FalconStor Software | Post-IPO Equity | 3.3M |
4/2021 | GIGA TRONICS | Post-IPO Equity | 1.5M |
6/2021 | Cambium Networks | Post-IPO Equity | 96M |
4/2021 | VIRTRA SYSTEMS | Post-IPO Equity | 18M |
4/2021 | VBL THERAPEUTICS | Post-IPO Equity | 28.4M |
5/2016 | SunBasket | Series A | 0 |
3/2021 | Thomson Resources | Post-IPO Equity | 3.9M |
12/2013 | AmpliPhi Biosciences | Post-IPO Equity | 18M |
11/2016 | Gazillion, Inc. | Series B | 4M |
5/2021 | Reed&s;s | Post-IPO Equity | 0 |
8/2006 | Natus Medical | Post-IPO Equity | 30.8M |
3/2017 | Biocept | Post-IPO Equity | 9.3M |
12/2021 | UNION | Series B | 0 |
6/2021 | Meta Materials | Post-IPO Equity | 160M |
4/2018 | Intec Pharma | Post-IPO Equity | 35.4M |
4/2021 | Ocugen | Post-IPO Equity | 0 |
12/2021 | UNION | Series B | 0 |
7/2021 | Riley Permian | Venture Round | 0 |
6/2021 | Meta Materials | Post-IPO Equity | 0 |
6/2021 | Cambium Networks | Post-IPO Equity | 0 |
6/2021 | FalconStor Software | Post-IPO Equity | 0 |
6/2021 | Celsius | Post-IPO Equity | 0 |
5/2021 | DMC Global | Funding Round | 0 |
5/2021 | Reed&s;s | Post-IPO Equity | 0 |
5/2021 | ADOMANI | Post-IPO Equity | 0 |
4/2021 | Ocugen | Post-IPO Equity | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|